Morimoto, R.; Matsubara, C.; Hanada, A.; Omoe, Y.; Ogata, T.; Isegawa, Y.
Effect of Structural Differences in Naringenin, Prenylated Naringenin, and Their Derivatives on the Anti-Influenza Virus Activity and Cellular Uptake of Their Flavanones. Pharmaceuticals 2022, 15, 1480.
https://doi.org/10.3390/ph15121480
AMA Style
Morimoto R, Matsubara C, Hanada A, Omoe Y, Ogata T, Isegawa Y.
Effect of Structural Differences in Naringenin, Prenylated Naringenin, and Their Derivatives on the Anti-Influenza Virus Activity and Cellular Uptake of Their Flavanones. Pharmaceuticals. 2022; 15(12):1480.
https://doi.org/10.3390/ph15121480
Chicago/Turabian Style
Morimoto, Ryosuke, Chiaki Matsubara, Akari Hanada, Yuta Omoe, Tokutaro Ogata, and Yuji Isegawa.
2022. "Effect of Structural Differences in Naringenin, Prenylated Naringenin, and Their Derivatives on the Anti-Influenza Virus Activity and Cellular Uptake of Their Flavanones" Pharmaceuticals 15, no. 12: 1480.
https://doi.org/10.3390/ph15121480
APA Style
Morimoto, R., Matsubara, C., Hanada, A., Omoe, Y., Ogata, T., & Isegawa, Y.
(2022). Effect of Structural Differences in Naringenin, Prenylated Naringenin, and Their Derivatives on the Anti-Influenza Virus Activity and Cellular Uptake of Their Flavanones. Pharmaceuticals, 15(12), 1480.
https://doi.org/10.3390/ph15121480